Clinical Trials Browser

NIH × Gliosarcoma × aldesleukin × Clear all

NCT01454596 2019-08-21

CAR T Cell Receptor Immunotherapy Targeting EGFRvIII for Patients With Malignant Gliomas Expressing EGFRvIII

Phase 1/2 Completed

18 enrolled 25 charts

Brain Neoplasms, Glioblastoma, Glioma, Gliosarcoma

NCT00003067 2009-02-09

Biological Therapy in Treating Patients With Primary or Advanced Glioma

Phase 2 Suspended

Astrocytoma, Brain Neoplasms, Glioblastoma, Glioma, Central Nervous System Neoplasms, Gliosarcoma